Ayr Wellness Inc. - Rights | CSE - Bourse des valeurs canadiennes

Ayr Wellness Inc. - Rights

Liste d'échange:

CSE

Statut:

Active

Industrie:

Life Sciences

Symbole:

AYR.RT

Indice CSE:

Devise:

Each Right entitles the holder to receive, for no additional consideration, one-tenth of one Subordinate Voting Share, subject to certain adjustments. Any Right that has not been converted by 5:00 p.m. on May 24, 2021 shall be null and void.

Ayr Strategies Inc. - Subordinate Voting Shares

Vous êtes ici

Ayr Wellness Inc. - Rights (AYR.RT)

SEDAR Information

Information d'entreprise

Addresse

590 Madison Avenue, 26th Floor

New York, NY 10022

États-Unis

Téléphone

949-574-3860

Fax

212-299-7666

Courriel

AYR@gatewayir.com

Date d’inscription à la cote

Lundi, août 19, 2019

Agent de transfert

Odyssey Trust Company

Capitalisation

Capitalisation:

1,506,788

Réservé à l'émission:

Communiqués de presse

19/11/2020

Ayr Strategies Completes Acquisition of DocHouse in Pennsylvania - Press Release November 19 2020

18/11/2020

Ayr Strategies Reports Third Quarter 2020 Results & Updates Investors on 2021 Expansion Initiatives - Press Release dated November 18, 2020

Bulletins

18/05/2021

2021-0519 – Amendement - Ayr Wellness Inc. 10DEC2024 Notes (AYR.NT.U)

Le 18 mai/May 2021

Further to bulletin 2021-0428 the First Accrued Interest Date has been amended to December 10, 2020.

______________________

Suite au bulletin 2021-0428, la première date des intérêts courus a été modifiée au 10 décembre 2020.

Dépôts CSE

Q3 2020 MD&A

Q3 2020 Interim Financial Statements

Form 6 - Certificate of Compliance - October 2020

Form 7 - Monthly Progress Report October 2020

reviewed Interim Financial Statements for the Q2 period ended June 30, 2020

Dépôts CSE

Fichier	Type	Date
Q3 2020 MD&A	MD & A (Discussion et analyse de la direction)	18/11/2020
Q3 2020 Interim Financial Statements	États financiers intermédiaires	18/11/2020
Form 6 - Certificate of Compliance - October 2020	Certificat de conformité	04/11/2020
Form 7 - Monthly Progress Report October 2020	Rapport d'activité mensuel	04/11/2020
reviewed Interim Financial Statements for the Q2 period ended June 30, 2020	États financiers intermédiaires	08/10/2020
Form 7 - Monthly Progress Report September 2020	Rapport d'activité mensuel	06/10/2020
Form 6 - Certificate of Compliance August 2020	Certificat de conformité	03/09/2020
Form 7 - Monthly Progress Report August 2020	Rapport d'activité mensuel	03/09/2020
Q2 Interim MD&A for the period ended June 30, 2020	MD & A (Discussion et analyse de la direction)	26/08/2020